was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
ViiV Healthcare is a global specialty Human Immunodeficiency Virus (HIV) company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV Healthcare is highly mission-d...
Territory includes New Brunswick, Princeton, Flemington, Basking Ridge, Summit, NJ, Lehigh valley, PA and Staten Island, NY. The ideal candidate should live in Central New Jersey or the surrounding areas. (Relocation assistance not prov...
GSK invites driven analytics professionals for the role of Manager, Market Access Payer & Provider Account Analytics. Positioned within the US Market Access Operations & Analytics division, this role is responsible for delivering impactful ...
Position Summary You will lead global medical activities for oncology assets and work closely with research, commercial, clinical operations, and local medical teams. You will shape evidence generation, guide external scientific engagemen...
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our u...